Nanalysis Scientific Corp.
NSCI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.15% | 90.18% | 9.65% | -5.20% | 51.32% |
| Total Depreciation and Amortization | -69.40% | 118.53% | -74.42% | -68.98% | -24.66% |
| Total Amortization of Deferred Charges | -- | -89.90% | -- | -- | -- |
| Total Other Non-Cash Items | -3.38% | -89.60% | -81.25% | -63.57% | -42.79% |
| Change in Net Operating Assets | -110.26% | 366.22% | 116.42% | -202.99% | 22.03% |
| Cash from Operations | -105.05% | 149.40% | 5.28% | -246.99% | 71.90% |
| Capital Expenditure | 29.26% | -- | -493.18% | -8,885.71% | -3.58% |
| Sale of Property, Plant, and Equipment | 157.14% | -73.06% | -96.17% | 83.59% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.22% | -15.08% | 25.96% | 30.76% | 4.99% |
| Cash from Investing | 67.55% | -98.26% | 13.91% | 21.05% | 5.90% |
| Total Debt Issued | -- | 21.97% | -22.64% | -- | -- |
| Total Debt Repaid | -6.84% | -119.63% | 103.30% | 85.75% | 35.28% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.22% | -10.81% | 9.52% | 3.66% | 40.37% |
| Cash from Financing | 21.21% | 76.24% | 511.38% | 234.81% | -5,415.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -274.43% | 139.31% | 107.23% | 36.79% | -167.21% |